Press Release · Press Releases
Bitmine Immersion Technologies (BMNR) annuncia che le partecipazioni in ETH hanno raggiunto 6,05 milioni di token e che il valore complessivo delle disponibilità in criptovalute, liquidità e titoli negoziabili ammonta a 15 miliardi di dollari
Bitmine ha riacquistato 2,04 milioni di azioni nella scorsa settimana Finora, nel 2026, Bitmine ha riacquistato complessivamente 22,9 milioni di azioni, realizzando il più grande riacquisto azionario mai effettuato da una società di tesoreria crypto Bitmine detiene il 4,95% dell'offerta...
This press release summary is reproduced from the issuer's public feed.
Read the full release at PR NewswireOriginal publisher: PR Newswire
Spotted an error? Request a correction · Corrections Policy
Related stories
Invesco Reports Results for the Three Months Ended September 30, 2026
Invesco Announces Third Quarter Diluted EPS of $0.65; Adjusted Diluted EPS (1) of $0.72 ATLANTA, Oct. 27, 2026 /PRNewswire/ -- Invesco Ltd. (NYSE: IVZ) today reported financial results for the three months ended September 30, 2026. $35.1 billion of net long-term inflows for the quarter,...
PR Newswire ·
Bybit Partners with XAUE Protocol to Offer 2.83% Fixed APR on XAUT Savings
DUBAI, UAE, Oct. 27, 2026 /PRNewswire/ -- Bybit, the New Financial Platform trusted by more than 80 million users worldwide, is pleased to launch a new fixed-term XAUT Savings offering in partnership with XAUE Protocol. On Bybit Easy Earn, eligible holders of Tether Gold (XAUT) will...
PR Newswire ·
Johnson Controls Reports Q4 and FY26 Results; Initiates FY27 Guidance
Q4 sales increased 10% and organic sales increased 12%* Q4 GAAP EPS of $1.60; Q4 Adjusted EPS* of $1.66* Q4 orders +44% organically year-over-year Backlog of $23.0 billion increased 43% organically year-over-year * This earnings release contains non-GAAP financial measures. Definitions...
PR Newswire ·
Vanda Pharmaceuticals Announces Positive Results from Study 3601 of NEREUS™ (tradipitant) for Prevention of GLP-1-Induced Vomiting
NEREUS™ significantly reduced semaglutide induced vomiting including frequent multi-day and extreme vomiting Key Results Any vomiting (primary) 43.0% (61/142) vs 58.5% (96/164) placebo (p=0.006); 27% relative reduction Vomiting + severe nausea (key secondary): 33.1% (47/142) vs 50.6%...
PR Newswire ·
Hodinky HUAWEI WATCH D3, poprvé představené na konferenci ISH-ECS 2026, přinášejí pokročilé monitorování krevního tlaku do každodenního života
DUBAJ, Spojené arabské emiráty, 27. října 2026 /PRNewswire/ -- Ve dnech 22. až 25. října 2026 se v Dubaji konalo 31. vědecké zasedání Mezinárodní společnosti pro hypertenzi a 17. výroční konference Emirátské kardiologické společnosti (ISH-ECS 2026). Jako významné mezinárodní zasedání...
PR Newswire ·
ECOVACS WINBOT W3 OMNI unter den „Best Inventions of 2026“ des TIME-Magazins
NEW YORK, 27. Oktober 2026 /PRNewswire/ -- ECOVACS ROBOTICS, ein weltweit führender Anbieter im Bereich der Haushaltsrobotik, gibt mit Stolz bekannt, dass sein WINBOT W3 OMNI in die Liste der „Best Inventions of 2026" des TIME-Magazins aufgenommen wurde[1]. Diese Auszeichnung...
PR Newswire ·